1.
Europe and the United States Approval System of Biosimilar and Its Enlightenment to China
欧美生物仿制药注册制度及对我国的启示
2.
Discussion about the construction of biowaiver system for oral generics
口服仿制药生物等效豁免体系构建探讨
3.
State Key Laboratory of Natural and Biomimetic Drugs
天然药物及仿生药物国家重点实验室
4.
Research on Modeling and Simulating to Independent Innovation Ecosystem of Marine Biopharmacy;
海洋生物制药自主创新生态系统建模与仿真研究
5.
Evaluation on the release discipline of baicalin and its three solid preparations using a drug dissolution and absorption simulating system
药物溶出/吸收仿生系统研究黄芩苷固体制剂的释放规律
6.
Blood biocompatibility of RNAⅢ inhibiting peptide/bioinspired phosphorylcholine-based cytomembrane coating
RNAⅢ抑制肽/磷酸胆碱基细胞膜仿生药物涂层的血液相容性(英文)
7.
Interpretion of FDA guidance on submission of summary bioequivalence data for abbreviated new drug application
FDA仿制药申请生物等效性数据资料提交指导原则介绍
8.
Introduction of WHO's Biowaiver Policy for Oral Generic Drugs
WHO关于口服仿制药生物等效豁免相关政策的介绍
9.
The Research on Biopharmaceutical Innovation Mechanism of Harbin Pharmaceutical Group
哈药集团发展生物制药创新机制研究
10.
The doctor is dispensing medicines.
该医生在配制药物。
11.
Biotech Drugs and Vaccines
生物技术制药与疫苗
12.
The word biomimic comes from bio, as in biology and mimetic, which means to copy.
仿生学是由「」仿、是复制，「」就是生物两个字组合而成。
13.
Synthesis of Drug Derivatives by Enzymatic Strategy and Preparation of Their Polymeric Prodrug;
酶促合成药物衍生物及其高分子前药的制备
14.
The Teaching of the Medicinal Chemsitry Course for Bio-pharmaceutical Specialty
生物制药专业课程中的药物化学教学的探讨
15.
Exploration of Bioinspired Preparation of SiO_2 Films on Historic Stones
仿生制备石质文物SiO_2防护膜的探索
16.
Study on the limit-controlling methods of microorganism in the Traditional Chinese Medicine pharmaceutics
中药制剂微生物限度控制方法的研究
17.
proprietary medicine not containing antibiotics, hormones, alkaloids or microbial products
专卖药,不含抗生素、激素、生物碱或微生物制品
18.
Drug Derivatization by Enzymatic Methods and Preparation of Optically Pure Drug and Polymeric Prodrug;
药物酶促方法衍生化与光学纯药物及高分子前药的制备